射频废除自主运作的甲状腺腺瘤的结果 - 梅奥诊所的经验
Maheswaran Dhanasekaran1, John Schmitz2, Maria Regina Castro1
1Department of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN 55905, USA.
Journal of the Endocrine Society
|November 6, 2024
概括
射频切除 (RFA) 有效地治疗自主功能甲状腺结节 (AFTNs),在90.9%的患者中解决甲状腺功能过高症. 与传统治疗相比,这种最少的侵入性选择可以显著减少结节体积,并具有有利的安全性.
科学领域:
- 内分泌学 在内分泌学.
- 最少侵入性手术的方法
- 在瘤学瘤学.
背景情况:
- 自主功能甲状腺结节 (AFTNs) 是甲状腺功能过高的常见原因.
- 目前的治疗方法,如放射性 (RAI) 和手术,存在甲状腺功能低下和其他并发症的风险.
研究的目的:
- 评估射频剥离 (RFA) 作为AFTNs的替代治疗方法.
- 评估RFA在解决甲状腺功能障碍和减少结节体积方面的有效性.
- 为了确定与RFA相关的不良事件对AFTNs.
主要方法:
- 22名单独AFTNs的患者接受了一次RFA会话.
- 监测了患者的治疗结果,以确定甲状腺功能障碍的解决,结节体积的减少和不良事件.
- 随访包括生物化学评估和结节大小测量.
主要成果:
- 甲状腺功能障碍在90.9%的患者中在一次RFA治疗后得到缓解.
- 在3-6个月内,结节体积的平均减少为61.13%.
- 轻微的不良事件包括过渡性高心率和轻度甲状腺功能低下症;没有报告严重并发症.
结论:
- 在治疗AFTNs方面,RFA显示出高效率和良好的安全性.
- RFA为RAI和手术提供了一个可行的替代方案,避免了相关的并发症.
- 考虑在有经验的中心为有毒腺瘤患者提供RFA.
更多相关视频
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.3K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.3K
相关概念视频
The Thyroid Gland
7.0K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
7.0K
Hyperthyroidism II: Pathophysiology
28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
